GSK2831781

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GSK2831781, covering 2019-08-16 to 2022-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis [Phase 2]